16 Geographic Atrophy Clinical Trials in Tampa, FL (2026)

Q: How do I join a clinical trial in Tampa?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tampa research site will contact you.

Recruiting Geographic Atrophy Studies in Tampa

NCT07221149Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

The purpose of this study is to evaluate the safety and efficacy of Pumitamig in combination with chemotherapy versus Nivolumab in combination with chemotherapy in participants with previously untreat...

Tampa, FLPHASE2690 participantsBristol-Myers Squibb

View Study Details

NCT07565428Recruiting

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

Evaluate the efficacy, as well as safety and pharmacokinetics, of Roluperidone in improving the negative symptoms of schizophrenia in adult subjects in Phase A of study, followed by Phase B of study t...

Tampa, FLPHASE3380 participantsMinerva Neurosciences

View Study Details

NCT05377996Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

A Study of Emi-Le in Participants with Solid Tumors...

Tampa, FLPHASE1360 participantsDay One Biopharmaceuticals, Inc.

View Study Details

NCT04787042Recruiting

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab \[Gazyva®\] pre-treatme...

Tampa, FLPHASE1316 participantsSimcha IL-18, Inc.

View Study Details

NCT02774746Recruiting

Gastroschisis Outcomes of Delivery (GOOD) Study

The objective of this study is to investigate the hypothesis that delivery at 35 0/7- 35 6/7 weeks in stable patients with gastroschisis is superior to observation and expectant management with a goal...

Tampa, FLNA300 participantsMedical College of Wisconsin

View Study Details

NCT07260916Recruiting

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

MINUTE is a prospective, multi-center, randomized, controlled, blinded assessor, adaptive enrichment design, clinical trial. Eligible patients with spontaneous BGH ≥20 mL will be randomized 1:1 to eit...

Tampa, FLNA300 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT05219617Recruiting

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic) compared with placebo in ped...

Tampa, FLPHASE3252 participantsSK Life Science, Inc.

View Study Details

NCT05115474Recruiting

Study of Screening Brain MRIs in Stage IV Breast Cancer

The study is a single arm, nonrandomized phase II prospective study, with the goal of investigating the role of screening brain MRIs in neurologically asymptomatic patients with metastatic breast canc...

Tampa, FLPHASE2170 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

NCT07539311Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

This Phase 2 study will be conducted in different countries around the world with up to about 160 participants. The purpose of this study is to evaluate how well Rina-S works against GI cancers. The...

Tampa, FLPHASE2160 participantsGenmab

View Study Details

NCT07015424Recruiting

Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass

The goal of this clinical trial is to evaluate weight loss with TORe and intensive lifestyle modification versus intensive lifestyle modification alone in subjects who have regained weight following a...

Tampa, FLNA108 participantsBoston Scientific Corporation

View Study Details

NCT07524946Recruiting

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris....

Tampa, FLPHASE4100 participantsBausch Health Americas, Inc.

View Study Details

NCT06624670Recruiting

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

The purpose of this study is to find out whether a medicine called spesolimab helps people with pyoderma gangrenosum (PG). The main aim is to see whether spesolimab leads to closure of PG ulcers. This...

Tampa, FLPHASE390 participantsBoehringer Ingelheim

View Study Details

NCT06497569Recruiting

Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer

The purpose of this study is to determine how the STRONG intervention compares with usual care for reducing malnutrition among gastroesophageal cancer patients....

Tampa, FLNA80 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

NCT06560307Recruiting

Study of Enhanced Programming Stimulation with the Enterra® Therapy System

The purpose of this research study is to evaluate if an enhanced Enterra device programming strategy will improve symptoms associated with gastroparesis, improve symptoms in a faster amount of time, a...

Tampa, FLNA50 participantsEnterra Medical, Inc.

View Study Details

NCT07406633Recruiting

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

This study will test an experimental drug called KQB198 in combination with imatinib. The goal is to determine if this combination is safe and tolerable and assess how effective the combination is at ...

Tampa, FLPHASE246 participantsKumquat Biosciences Inc.

View Study Details

NCT05504707Recruiting

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

The purpose of the study is to find out if an investigational vaccine called Dendritic Cell (DC) vaccine given together with standard of care chemotherapy drugs can help people with Triple Negative an...

Tampa, FLPHASE130 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

About Geographic Atrophy Clinical Trials in Tampa

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 16 geographic atrophy clinical trials recruiting participants in Tampa, FL. These studies are seeking a combined 3,432 participants. Research is being sponsored by Bristol-Myers Squibb, Minerva Neurosciences, Day One Biopharmaceuticals, Inc. and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Tampa — FAQ

Are there geographic atrophy clinical trials in Tampa?

Yes, there are 16 geographic atrophy clinical trials currently recruiting in Tampa, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tampa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tampa research site will contact you about next steps.

Are clinical trials in Tampa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tampa studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 16 active trials in Tampa are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 12, 2026 from ClinicalTrials.gov